Evome Medical Technologies Posts Third Quarter 2024 Results, Generates $424,000 in Adjusted EBITDA on Stable Revenues, Further Reduces Debt
SHIRLEY, N.Y., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Shirley, New York, November 25, 2024 – Evome Medical Technologies Inc. (the “Company”) (TSXV:...